REFERENCES
- Barry HC: Paget's Disease of Bone. Baltimore, The Williams & Wilkins Co, 1969
- Franck WA, Bress NM, Singer FR, et al: Rheumatic manifestations of Paget's disease of bone. Am J Med 56: 592, 1974
- Nagant de Deuxchaisnes C, Krane SM: Paget's disease of bone: Clinical and metabolic observations. Medicine 43: 233, 1964
- Khairi MR, Wellman HN, Robb JA, et al: Paget's disease of bone (osteitis deformans): Symptomatic lesions and bone scan. Ann Intern Med 79: 348, 1973
- Miller SW, Castronovo FP Jr, Pendergrass HP, et al: Technetium 99M labeled diphosphonate bone scanning in Paget's disease. Radiology 121: 177, 1974
- Bijvoet OL, van der Sluys Veer J, Jansen AP: Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia. Lancet 1: 876, 1968
- Greenberg PB, Doyle FH, Fisher MT, et al: Treatment of Paget's disease of bone with synthetic human calcitonin: Biochemical and roentgenologic changes. Am J Med 56: 867, 1974
- DeRose J, Singer FR, Avramides A, et al: Response of Paget's disease to porcine and salmon calcitonins: Effects of long-term treatment. Am J Med 56: 858, 1974
- Woodhouse NJ, Bordier P, Fisher M, et al: Human calcitonin in the treatment of Paget's bone disease. Lancet 1: 1139, 1971
- Singer FR, Keutmann HT, Neer RM, et al: Pharmacological effects of salmon calcitonin in man. In Talmage RV, Munson PL (Editors): Calcium, Parathyroid Hormone and the Calcitonins. Amsterdam, Excerpta Medica, 1972, p 89
- Kanis JA, Horn DB, Scott RD, et al: Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J 3: 727, 1974
- Avramides A, Baker RK, Wallach S: Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone. Metabolism 23: 1037, 1974
- Singer FR, Aldred JP, Neer RM, et al: An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest 51: 2331, 1972
- Haddad JG Jr, Caldwell JG: Calcitonin resistance: Clinical and immunological studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest 51: 3133, 1972
- Rojanasathit S, Rosenberg E, Haddad JG Jr: Paget's bone disease: Response to human calcitonin by subjects resistant to salmon calcitonin. Lancet 2: 1412, 1974
- Ryan WG, Schwartz TB, Perlia CP: Effects of mithramycin on Paget's disease of bone. Ann Intern Med 70: 549, 1969
- Lebbin D, Ryan WG, Schwartz TB: Outpatient treatment of Paget's disease of bone with mithramycin. Ann Intern Med 81: 635, 1974
- Smith R, Russell RG, Bishop M: Diphosphonates and Paget's disease of bone. Lancet 1: 945, 1971
- Altman RD, Johnston CC, Khairi MR, et al: Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med 289: 1379, 1973
- Guncaga J, Lauffenburger T, Lentner C, et al: Diphosphonate treatment of Paget's disease of bone. Horm Metab Res 6: 62, 1974
- Russell RG, Smith R, Preston C, et al: Diphosphonates in Paget's disease. Lancet 1: 894, 1974
- DeVries HR, Bijvoet OL: Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate. Neth J Med (in press)